Handelsinvest Investeringsforvaltning Allakos Inc. Transaction History

Handelsinvest Investeringsforvaltning

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 02, 2021	SELL	$76.53 - $110.43 $2.14 Million - $3.09 Million	-28,000 Closed	0 $0
Q1 2021 Apr 20, 2021	SELL	$109.73 - $153.66 $219,460 - $307,320	-2,000 Reduced 6.67%	28,000 $3.21 Million
Q3 2020 Oct 26, 2020	BUY	$66.43 - $90.99 $664,300 - $909,900	10,000 Added 50.0%	30,000 $2.44 Million
Q1 2020 Apr 30, 2020	BUY	$44.49 - $93.39 $889,800 - $1.87 Million	20,000 New	20,000 $890,000

64.7M

47.1K

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $108M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

Get notified when there are updates to the investment portfolio of Handelsinvest Investeringsforvaltning, based on Form 13F filings with the SEC.

Stay updated on Handelsinvest Investeringsforvaltning with notifications on news.